XML 90 R77.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 01, 2022
USD ($)
shares
Jan. 31, 2022
USD ($)
Dec. 16, 2021
Aug. 18, 2021
USD ($)
installment
Apr. 05, 2021
USD ($)
installment
Apr. 01, 2021
USD ($)
Mar. 31, 2021
USD ($)
installment
Sep. 30, 2020
shares
Mar. 21, 2018
USD ($)
Feb. 28, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
installment
shares
Dec. 31, 2021
USD ($)
Apr. 30, 2023
USD ($)
Jan. 31, 2023
USD ($)
Jul. 31, 2022
USD ($)
Jun. 15, 2022
USD ($)
Commitments and Contingencies                                  
Research and development                       $ 3,977,563 $ 1,662,183        
Prepaid expenses                       500,000          
Annual royalty payment amount                       6,304 2,558        
Number of installments | installment             3                    
Repayments of notes payable                       $ (1,000,000) (2,450,000)        
Restricted common stock                                  
Commitments and Contingencies                                  
Number of shares, granted | shares                       3,310,000          
Lead Independent Director                                  
Commitments and Contingencies                                  
Aggregate amount spend on agreement $ 150,000                                
Number of market-based awards vested | shares                       37,500          
Non-Lead Independent Director                                  
Commitments and Contingencies                                  
Aggregate amount spend on agreement $ 95,000                                
Number of market-based awards vested | shares                       7,500          
Patent License Agreement                                  
Commitments and Contingencies                                  
Research and development                 $ 12,000                
Patent License Agreement | Minimum                                  
Commitments and Contingencies                                  
Percentage of royalty on net sale price                 1.50%                
Annual royalty payment amount                 $ 0                
Patent License Agreement | Maximum                                  
Commitments and Contingencies                                  
Percentage of royalty on net sale price                 3.75%                
Annual royalty payment amount                 $ 7,500                
Technology Development and Sponsorship Agreement                                  
Commitments and Contingencies                                  
Committed sponsorship fees             $ 900,000                    
Committed technology development fees             $ 750,000                    
Prepaid expenses                       $ 300,000          
Expense recognized                       $ 250,000          
Number of installments | installment                       3          
Additional installment amount due   $ 300,000       $ 250,000           $ 0          
Sponsorship fees                       1,350,000          
Sponsorship agreement term     1 year                            
Sponsorship agreement fees                               $ 500,000 $ 1,450,000
Research and Development Agreements                                  
Commitments and Contingencies                                  
Aggregate amount spend on agreement         $ 580,375                        
Expense recognized                       290,188          
Expense recognized under the agreement                       217,641          
Number of installments | installment         8                        
Additional installment amount due         $ 72,547                        
Term of agreement         2 years                        
Consulting agreement                                  
Commitments and Contingencies                                  
Consultant agreement term               2 years                  
Shares to be issued under Consulting Agreement | shares               60,000                  
Stock-based compensation expense                       25,545 46,455        
Multi-year research and development agreement                                  
Commitments and Contingencies                                  
Aggregate amount spend on agreement       $ 592,196                          
Expense recognized                       $ 296,100 $ 123,375        
Number of installments | installment       8                          
Additional installment amount due       $ 74,025                          
Common Stock                                  
Commitments and Contingencies                                  
Shares issued during period shares other | shares                       255,240          
Shares issued other value                       $ 399,018          
Common Stock | Restricted Stock Units                                  
Commitments and Contingencies                                  
Shares issued during period shares other | shares 100,000                                
Shares issued other value $ 205,000                                
Subsequent event                                  
Commitments and Contingencies                                  
Annual royalty payment amount                   $ 20,000              
Subsequent event | Technology Development and Sponsorship Agreement                                  
Commitments and Contingencies                                  
Additional installment amount due                     $ 350,000            
Sponsorship agreement fees                           $ 475,000 $ 475,000